During the past decade, Dres.Jochen Wilke und Harald Wagner conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dres.Jochen Wilke und Harald Wagner" #1 collaborator was "Breast International Group" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Dres.Jochen Wilke und Harald Wagner" are "Breast Cancer" (2 trials), "Non-Small Cell Lung Cancer (NSCLC)" (1 trials) and "Urothelial Carcinoma" (1 trials). Many other conditions were trialed in "Dres.Jochen Wilke und Harald Wagner" in a lesser frequency.

Most popular intervention types in "Dres.Jochen Wilke und Harald Wagner" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "5-Fluorouracil" (2 trials), "Atezolizumab" (2 trials), "Cyclophosphamide" (2 trials), "Docetaxel" (2 trials) and "Doxorubicin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Dres.Jochen Wilke und Harald Wagner" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Dres.Jochen Wilke und Harald Wagner". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Dres.Jochen Wilke und Harald Wagner, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dres.Jochen Wilke und Harald Wagner, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".